Beta-Cryptoxanthin, a Novel Carotenoid Derived from Satsuma Mandarin, Prevents Abdominal Obesity

Nutrition in the Prevention and Treatment of Abdominal Obesity

Volumn , Issue , 2014, Pages 381-399

  Takayanagi, Katsuhiko ^a   Mukai, Katsuyuki ^a  

^a UNITIKA LTD   (Japan)

Author keywords

3T3 L1; LE540; Metabolic syndrome; Obesity; PPAR ; Satsuma mandarin; TSOD; Visceral fat; cryptoxanthin

Indexed keywords

EID: 84902614653     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-407869-7.00034-9     Document Type: Chapter

References (67)

1. Smith TA Carotenoids and cancer: prevention and potential therapy. Br J Biomed Sci 1998, 55:268-275.
2. Young AJ, Lowe GM Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys 2001, 385:20-27.
3. Mangels AR, Holden J, Beecher M, Beecher GR, Forman MR, Lanza E Carotenoid content of fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc 1993, 93:284-296.
4. Sugiura M, Kato M, Matsumoto H, Nagao A, Yano M Serum concentration of β-cryptoxanthin in Japan reflects the frequency of Satsuma mandarin (Citrus unshiu Marc.) consumption. J Health Sci 2002, 48:350-353.
5. Sugiura M, Matsumoto H, Kato M, Ikoma Y, Yano M, Nagao A Multiple linear regression analysis of the seasonal changes in the serum concentration of β-cryptoxanthin. J Nutr Sci Vitaminol 2004, 50:196-202.
6. Bramlev PV Is lycopene beneficial to human health?. Phytochemistry 2000, 54:233-236.
7. Cooney RV, Bertram JS, Hankin JH, Kolonel LN, Miyake A, Billings K, et al. Relationship between dietary, serum, and tissue levels of carotenoids. Cancer Lett 1991, 61:81-87.
8. Glise D, Riondel J, Favier A Comparative distribution of b-carotene and lycopene after intraperitoneal administration in mice. In Vivo 1998, 12:447-454.
9. Kaplan LA, Lau JM, Stein EA Carotenoid composition, concentration, and relationships in various human organs. Clin Physiol Biochem 1990, 8:1-10.
10. Nair PP, Lohani A, Norkus EP, Feagins H, Bhagavan HN Uptake and distribution of carotenoids, retinal, and tocopherols in human colonic epithelial cells in vivo. Cancer Epidemiol Biomarkers Prev 1996, 5:913-916.
11. Sugiura M, Nakamura M, Ikoma Y, Yano M, Ogawa K, Matsumoto H, et al. High serum carotenoids are inversely associated with serum γ-glutamyltransferase in alcohol drinkers within normal liver function. J Epidemiol 2005, 15:180-186.
12. Sugiura M, Nakamura M, Ikoma Y, Yano M, Ogawa K, Matsumoto H, et al. Serum carotenoid concentrations are inversely associated with serum aminotransferases in hyperglycemic subjects. Diabetes Res Clin Pract 2006, 71:82-91.
13. Nishino H, Tokuda H, Murakoshi M, Satomi Y, Masuda M, Onozuka M, et al. Cancer prevention by natural carotenoids. Biofactors 2000, 13:89-94.
14. Rauscher R, Edenharfer R, Platt KL In vitro antimutagenic and in vivo anticlasogenic effects of carotenoids and solvent extracts from fruits and vegetables rich in carotenoids. Mutat Res 1998, 413:129-142.
15. Tanaka T, Kohno H, Murakami M, Shimada R, Kagami S, Sumida T, et al. Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats my mandarin juices rich in β-cryptoxanthin and hesperidin. Int J Cancer 2000, 88:146-150.
16. Uchiyama S, Yamaguchi M Oral administration of β-cryptoxanthin prevents bone loss in ovariectomized rats. Int J Mol Med 2006, 17:15-20.
17. Sugiura M, Nakamura M, Ogawa K, Ikoma Y, Ando F, Yano M Bone mineral density in post-menopausal female subjects is associated with serum antioxidant carotenoids. Osteoporos Int 2008, 19:211-219.
18. Sugiura M, Nakamura M, Ogawa K, Ikoma Y, Ando F, Shimokata H, et al. Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: findings from post-menopausal Japanese female subjects. Osteoporos Int 2011, 22:143-152.
19. Sugiura M, Nakamura M, Ikoma Y, Yano M, Ogawa K, Matsumoto H, et al. The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol 2006, 16:71-78.
20. Sugiura M, Ogawa K, Yano M Effect of chronic administration of fruit extract (Citrus unshiu Marc.) on glucose tolerance in GK rats, a model of type 2 diabetes. Biosci Biotechnol Biochem 2006, 70:293-295.
21. Sugiura M, Matsumoto H, Kato M, Ikoma Y, Yano M, Nagao A Seasonal changes in the relationship between serum concentration of β-cryptoxanthin and serum lipid levels. J Nutr Sci Vitaminol (Tokyo) 2004, 50:410-415.
22. Tsuchida T, Minagawa K, Mukai K, Mizuno Y, Mashiko K, Minagawa K The comparative study of β-cryptoxanthin derived from Satsuma mandarin for fat of human body. Jpn Pharmacol Ther 2008, 36:247-253.
23. Hirayama I, Yi Z, Izumi S, Arai I, Suzuki W, Nagamachi Y, et al. Genetic analysis of obese diabetes in the TSOD mouse. Diabetes 1999, 48:1183-1191.
24. Suzuki W, Iizuka S, Tabuchi M, Funo S, Yanagisawa T, Kimura M, et al. A new mouse model of spontaneous diabetes derived from ddY strain. Exp Anim 1999, 48:181-189.
25. Wahlqvist ML, Wattanapenpaiboon N, Macrae FA, Lambert JR, MacLennan R, Hsu-Hage BH Changes in serum carotenoids in subjects with colorectal adenomas after 24 mo of 6-carotene supplementation. Am J Clin Nutr 1994, 60:936-943.
26. Michaud DS, Giovannucci EL, Ascherio A, Rimm EB, Forman MR, Sampson L, et al. Associations of plasma carotenoid concentrations and dietary intake of specific carotenoids in samples of two prospective cohort studies using a new carotenoid database. Cancer Epidemiol Biomarker Prev 1998, 7:283-290.
27. Jenkins DJ, Popovich DG, Kendall CW, Vidgen E, Tariq N, Ransom TP, et al. Effect of a diet high in vegetables, fruit, and nuts on serum lipids. Metabolism 1997, 46:530-537.
28. Feldman EB Fruits and vegetables and the risk of stroke. Nutr Rev 2001, 59:24-27.
29. Ford ES, Mokdad AH Fruit and vegetable consumption and diabetes mellitus incidence among U.S. adults. Prev Med 2001, 32:33-39.
30. Terry P, Terry JB, Wolk A Fruit and vegetable consumption in the prevention of cancer: an update. J Intern Med 2001, 250:280-290.
31. Campbell DR, Gross MD, Martini MC, Grandits GA, Stavin JL, Potter JD Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev 1994, 3:493-500.
32. Drewnowski A, Rock CL, Henderson SA, Shore AB, Fischler C, Galan P, et al. Serum b-carotene and vitamin C as biomarkers of vegetable and fruit intakes in a community-based sample of French adults. Am J Clin Nutr 1997, 65:1796-1802.
33. Tucker KL, Chen H, Vogel S, Wilson PW, Schaefer EJ, Lammi-Keefe CJ Carotenoid intakes, assessed by dietary questionnaire, are associated with plasma carotenoid concentrations in an elderly population. J Nutr 1999, 129:438-445.
34. van Kappel AL, Steghens JP, Zeleniuch-Jacquotte A, Chajes V, Toniolo P, Riboli E Serum carotenoids as biomarkers of fruit and vegetable consumption in the New York Women's Health Study. Public Health Nutr 2001, 4:829-835.
35. Papas A, Stacewicz-Sapuntzakis M, Lagiou P, Bamia C, Chloptsios Y, Trichopoulou A Plasma retinol and tocopherol levels in relation to demographic, lifestyle and nutritional factors of plant origin in Greece. Br J Nutr 2003, 89:83-87.
36. Nakamura M, Sugiura M, Aoki N High beta-carotene and beta-cryptoxanthin are associated with low pulse wave velocity. Atherosclerosis 2006, 184:363-369.
37. Montonen J, Knekt P, Järvinen R, Reunanen A Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004, 27:362-366.
38. Suzuki K, Ito Y, Ochiai J, Kusuhara Y, Hashimoto S, Tokudome S, et al. Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev 2003, 4:259-266.
39. Takaishi N, Satsu H, Takayanagi K, Mukai K, Shimizu M In vivo and in vitro studies on the absorption characteristics of b-cryptoxanthin in the intestine. Biosci Biotechnol Biochem 2012, 76:120511-120515.
40. Huang DW, Sherman BT, Lempicki RA Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
41. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010, 38:D355-D360.
42. Hertzel AV, Smith LA, Berg AH, Cline GW, Shulman GI, Scherer PE, et al. Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am J Physiol Endocrinol Metab 2006, 290:814-823.
43. Choi BH, Kim YH, Ahn IS, Ha JH, Byun JM, Do MS The inhibition of inflammatory molecule expression on 3. T3-L1 adipocytes by berberine is not mediated by leptin signaling. Nutr Res Pract 2009, 3:84-88.
44. Ajuwon KM, Spurlock ME Adiponectin inhibits LPS-induced NF&-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005, 288:1220-1225.
45. Iizuka S, Suzuki W, Tabuchi M, Nagata M, Imamura S, Kobayashi Y, et al. Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity. Exp Anim 2005, 54:71-83.
46. Kawada T, Miyata S, Shimada T, Sanzen Y, Ito M, Hemmi C, et al. A study of cardiovascular function in Tsumura Suzuki obese diabetes, a new model mouse of type 2 diabetes. Biol Pharm Bull 2010, 33:998-1003.
47. Rabe K, Lehrke M, Parhofer KG, Broedl UC Adipokines and insulin resistance. Mol Med 2008, 14:741-751.
48. Mourier A, Gautier JF, De Kerviler E, Bigard AX, Villette JM, Garnier JP, et al. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM: effects of branched-chain amino acid supplements. Diabetes Care 1997, 20:385-391.
49. Issemann I, Green S Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347:645-650.
50. Matsumoto A, Mizukami H, Mizuno S, Umegaki K, Nishikawa J, Shudo K, et al. β-Cryptoxanthin, a novel natural RAR ligand, induces ATP-binding cassette transporters in macrophages. Biochem Pharmacol 2007, 74:256-264.
51. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 1994, 135:798-800.
52. Yoon M The role of PPARγ in lipid metabolism and obesity: focusing on the effect of estrogen on PPARα actions. Pharmacol Res 2009, 60:151-159.
53. Schwarz EJ, Reginato MJ, Shao D, Krakow SL, Lazar MA Retinoic acid blocks adipogenesis by inhibiting C/EBPβ-mediated transcription. Mol Cell Biol 1997, 17:1552-1561.
54. Fu M, Sun T, Bookout AL, Downes M, Yu RT, Evans RM A nuclear receptor atlas: 3T3-L1 adipogenesis. Mol Endocrinol 2005, 19:2437-2450.
55. Sandouk T, Reda D, Hofmann C Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 1993, 264:C1600-C1608.
56. Noon LA, Clark AJ, King PJ A peroxisome proliferator-response element in the murine mc2-r promoter regulates its transcriptional activation during differentiation of 3T3-L1 adipocytes. J Biol Chem 2004, 279:22803-22808.
57. Saito A, Sugawara A, Uruno A, Kudo M, Kagechika H, Sato Y, et al. All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology 2007, 148:1412-1423.
58. Saito T, Abe D, Sekiya K Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes. Biochem Biophys Res Commun 2007, 357:371-376.
59. Karamanlidis G, Karamitri A, Docherty K, Hazlerigg DG, Lomax MA C/EBPβ reprograms white 3T3-L1 preadipocytes to a Brown adipocyte pattern of gene expression. J Biol Chem 2007, 282:24660-24669.
60. Hertzel AV, Smith LA, Berg AH, Cline GW, Shulman GI, Scherer PE, Bernlohr DA Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am J Physiol Endocrinol Metab 2006, 290:E814-E823.
61. Bour G, Plassat JL, Bauer A, Lalevée S, Rochette-Egly C Vinexin beta interacts with the non-phosphorylated AF-1 domain of retinoid receptor γ (RAR γ) and represses RARγ-mediated transcription. J Biol Chem 2005, 280:17027-17037.
62. Bry K, Lappalainen U Pathogenesis of bronchopulmonary dysplasia: the role of interleukin 1β in the regulation of inflammation-mediated pulmonary retinoic acid pathways in transgenic mice. Semin Perinatol 2006, 30:121-128.
63. Yarali N, Tavil B, Kara A, Ozkasap S, Tunç B Acute renal failure during ATRA treatment. Pediatr Hematol Oncol 2008, 25:115-118.
64. Kirfel J, Kelter M, Cancela LM, Price PA, Schüle R Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene. Proc Natl Acad Sci USA 1997, 94:2227-2232.
65. Marchildon F, St-Louis C, Akter R, Roodman V, Wiper-Bergeron NL Transcription factor Smad3 is required for the inhibition of adipogenesis by retinoic acid. J Biol Chem 2010, 285:13274-13284.
66. Okada T, Nakai M, Maeda H, Hosokawa M, Sashima T, Miyashita K Suppressive effect of neoxanthin on the differentiation of 3T3-L1 adipose cells. J Oleo Sci 2008, 56:345-351.
67. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005, 338:694-699.